OtherArticle
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel
Yumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko Ikeda
Drug Metabolism and Disposition December 1, 2008, DOI: https://doi.org/10.1124/dmd.108.022988
Yumi Nishiya
Katsunobu Hagihara
Takashi Ito
Masami Tajima
Shin-ichi Miura
Atsushi Kurihara
Nagy A. Farid
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel
Yumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko Ikeda
Drug Metabolism and Disposition December 1, 2008, DOI: https://doi.org/10.1124/dmd.108.022988
OtherArticle
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel
Yumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko Ikeda
Drug Metabolism and Disposition December 1, 2008, DOI: https://doi.org/10.1124/dmd.108.022988
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement